DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study

BACKGROUND: Alpha glucosidase inhibitor (GI) attenuates postprandial hyperglycemia (PPH) and reduces the risk of cardiovascular events in patients with impaired glucose tolerance or type 2 diabetes. Dipeptidyl peptidase 4 (DPP-4) inhibitors also attenuate PPH. PPH is one of the factors leading to en...

詳細記述

保存先:
書誌詳細
主要な著者: Nakamura, Kazufumi, Oe, Hiroki, Kihara, Hajime, Shimada, Kenei, Fukuda, Shota, Watanabe, Kyoko, Takagi, Tsutomu, Yunoki, Kei, Miyoshi, Toru, Hirata, Kumiko, Yoshikawa, Junichi, Ito, Hiroshi
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2014
主題:
Original Investigation
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4149239/
https://ncbi.nlm.nih.gov/pubmed/25074318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-014-0110-2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料